Cancer, Race, and the System That Wasn't Built for You

A Black oncologist was speaking at a conference about cancer awareness in Black communities when she said something that has stayed with people who heard it. She said that some of the Black teenage girls she worked with believed breast cancer was a white woman's disease.

Not because they were uninformed. Because they had looked at the evidence available to them — every poster, every campaign, every leaflet, every awareness month — and drawn a completely rational conclusion from what they saw. The women in the images were white. Therefore the disease was something that happened to white women. Therefore it was not something to worry about for themselves.

They were wrong about the conclusion and right about the evidence. For decades, the images in cancer campaigns, on hospital posters, on charity fundraising materials, in the magazines that ran awareness pieces in October — the faces were predominantly white. The campaigns were not designed with these girls in mind. The system that was supposed to warn them that they too are at risk spent those decades talking to someone else.

That gap has had consequences. Black women are less likely to be diagnosed early with breast cancer. South Asian women's uptake of cervical screening is lower than any other ethnic group in the UK. One in four Black men will be diagnosed with prostate cancer — double the rate for all men — and most of them don't know it. The awareness that was supposed to reach these communities didn't reach them, partly because the communities were never quite the intended audience.

This chapter is a different kind of resource. Not a campaign with the right intentions but the wrong images. Not a diversity commitment in an annual report. A conversation with you specifically — someone who has been through cancer treatment in the UK, from a community that the system was not built for — about what the system has and hasn't done, what specific help actually exists, and what a few specific conversations could change. In your life, and in the lives of people around you.

The organisations named throughout this chapter are mostly run by people from the communities they serve. The support that actually reaches South Asian women with cancer is delivered by South Asian women who have been through cancer. The prostate cancer advocacy that reaches Black men is led by Black men. That is not coincidence. It is the point. The help that actually helps tends to look like the person it is helping.

What happened in your clinical appointments

You may have sat in cancer appointments — during treatment, at diagnosis, at follow-up — and felt something you couldn't quite name. That the appointment was slightly shorter than it should have been. That your concern was absorbed rather than responded to. That information was offered less fully than you would have expected. That when you asked too many questions, something shifted in the room.

You may have told yourself you were imagining it. You may have been told you were imagining it.

The Scottish Government published a systematic review in November 2025 covering ethnic and racialised inequalities across the entire cancer pathway in the UK. It documented specifically: dismissal of symptoms. Delayed diagnosis attributed to racial bias. More positive behaviour by clinical staff toward White patients compared with those from minority ethnic backgrounds. Patients from ethnic minority communities being perceived as aggressive or over-assertive for asking questions that White patients ask without comment.

These are not anecdotes. They are documented, consistent, replicated findings from a comprehensive national review covering fifteen years of evidence.

The National Cancer Patient Experience Survey has run every year since 2010. Every single year without exception, Black and Asian patients have reported poorer experiences of cancer services than White patients. Every year. Fifteen consecutive surveys. The NHS Race and Health Observatory published its Cost of Racism report in March 2025 and was explicit: late cancer diagnoses, unequal access to clinical trials, disparities in the quality of care — not aberrations, not random variation. The predictable consequences of a system that has not adequately addressed its own structural failures.

If something felt wrong, it probably wasn't your imagination. You were experiencing the documented consequence of a system that has not yet treated communities like yours with the equity that it promises and has not yet delivered.

This is not said to generate anger about the past — you have enough to carry — but because you deserve to have your own experience confirmed rather than managed. Something has been done that should not have been done, to communities that did not deserve it. That is the honest starting point.

Prostate cancer and Black men

One in four Black African and Caribbean men in the UK will be diagnosed with prostate cancer in their lifetime. The figure for all men is one in eight. Black men are at least twice as likely to develop it as White men. They are twice as likely to die from it. The Caribbean population has the highest prostate cancer mortality rate in the world.

These figures have been known for decades. They are not disputed. More than 2,000 Black men will die from prostate cancer over the next decade if current rates continue unchanged.

The reason that number is so high is partly genetic, partly to do with the silence that surrounds prostate cancer in many Black communities, and partly to do with a system that has consistently put the responsibility for getting tested on the person at risk rather than on the institutions with the power to reach them. GPs are currently told not to raise PSA testing proactively with any asymptomatic man. Which means the men who get tested are the ones who already know to ask. And the men who don't know — who never saw themselves in the campaign, who were never told directly — don't ask, because they don't know there is something to ask.

Here is what you need to know, right now, specifically.

Black men aged 45 and over have the right to ask their GP for a PSA blood test. This was confirmed in the 2024 clinical consensus published in the British Journal of General Practice, agreed by a panel of UK clinicians. Any Black man aged 45 or over who has considered the advantages and disadvantages has the right to request this test. The GP cannot refuse a discussion.

The PSA test is a blood test. A raised result is not a cancer diagnosis — it is a signal that further investigation is warranted. And prostate cancer found early is almost always treatable. What is killing Black men in disproportionate numbers is prostate cancer found late, or not found at all.

If you are a Black man aged 45 or over: go to your GP and say these words — I am a Black man aged 45 and over and I would like to discuss having a PSA blood test, in line with NHS guidance on elevated risk in Black men. If you meet resistance, call Prostate Cancer UK's Risk Information Service on 0800 448 0821. Use their online Risk Checker at prostatecanceruk.org/risk-checker to understand your personal risk and what to do about it.

And then tell someone. A father, a brother, a son, an uncle, a friend. The silence around prostate cancer in Black communities is real, documented, and understandable — it exists in a community where cancer has often not been named, where masculinity and health intersect in specific ways, where the historical relationship with medical institutions has not reliably given those institutions the benefit of the doubt. The silence is not a failing. It is a response to a real set of pressures.

But it costs lives. And the most direct counter to it is not a campaign poster. It is a conversation between people who trust each other. One person who knows telling one person who doesn't. That is where this changes.

After prostate cancer treatment — the things that don't get said

If you are a Black man who has been through prostate cancer treatment, you may be living with consequences that the clinical system addresses in terms of mechanism and management but not in terms of what it actually means to carry them in your specific community.

Erectile dysfunction after radical prostatectomy affects the majority of men in the first year. Urinary incontinence affects a significant proportion. These are medical consequences of a medical decision. They are not a verdict on who you are.

But in a community where these subjects carry a specific weight — where masculinity is defined in particular ways, where cancer is often not named within families, where sexual dysfunction sits in an area of intense private shame — the gap between what the clinical system offers and what is actually needed is wide. Many men carry it alone. The shame of the side effect becomes a second thing to manage on top of the side effect itself.

Cancer Black Care, a charity founded in 1995 by a man whose brother died of prostate cancer after finding that culturally specific support simply didn't exist, provides peer support and counselling for people from Black and African Caribbean communities affected by cancer. They understand this specific terrain — not from outside, but from inside it. Contact: cancerblackcare.org.uk, phone 07340 471 970.

Prostate Cancer UK's helpline is 0800 074 8383. Their website at prostatecanceruk.org has specific information and peer support options for Black men navigating life after treatment.

You do not have to carry this alone. The side effects are medical. The shame is not deserved.

Black women and breast cancer — the age the system misses, and the tissue it can't see

The teenage girls at the start of this chapter were told something true that is also incomplete.

Black women do have a lower overall incidence of breast cancer than White women. But the NHS breast screening programme invites women for a mammogram when they turn 50. Research from an East London hospital found that Black women present with breast cancer at a median age of 46 — White women at 67. A twenty-one year difference. Black African and West African women show peak incidence of triple-negative breast cancer between 35 and 45. The invitation at 50 doesn't reach a Black woman at 37. And by 50, for some of these women, the window that mattered has already passed.

Triple-negative breast cancer deserves a specific word because it is the subtype that disproportionately affects Black women, and it behaves differently from the breast cancer that most awareness campaigns describe. It doesn't respond to hormonal therapies. It grows faster. It is more aggressive. And it often presents not as a gradual change noticed over months but as a lump that was not there last month. The standard advice — watch for changes over time — is incomplete here. A fast-growing lump in a woman in her thirties or forties is something to take to her GP the week she finds it.

Now there is a second specific problem that almost no patient-facing resource names. Black women are more likely to have dense breast tissue than White women. Dense breast tissue shows as white on a mammogram. Cancerous tumours also show as white. Trying to find a cancer in dense breast tissue is, in clinical shorthand, like looking for a cotton wool ball in a snowstorm. In very dense breasts, standard mammography can miss up to 40 per cent of cancers that are actually present. Dense breast tissue is also, independently, a risk factor for developing breast cancer in the first place. So Black women are more likely to have the tissue type that hides cancer from the test designed to find it, and the tissue type that increases their risk of developing it.

In the UK right now, you are not told whether your breasts are dense after a mammogram. The United States has required density notification since September 2024. The European Society of Breast Imaging recommended it in 2022. The UK has not yet mandated it. In May 2025 the BRAID trial, published in The Lancet, tested supplemental imaging for women with dense breasts who had clear mammograms. Abbreviated MRI found 17 additional cancers per 1,000 women. Contrast-enhanced mammography found 19. Standard mammography alone finds approximately 8 in dense breasts. This trial will change NHS policy. The problem: it was conducted in women aged 50 to 70. Black women's risk peaks before that threshold.

What you can do right now, if you are a Black woman under 50.

Check your breasts every month. Monthly — so that you know what is normal for you and can notice a change when it arrives. A fast-growing lump in a woman in her thirties is something to take to her GP the week she finds it, not the month after. Breast Cancer Now at breastcancernow.org has a clear guide to what to look and feel for.

If you are in your 40s and concerned about your risk, ask your GP for a referral to a breast clinic or a risk assessment. Say specifically: I am a Black woman in my 40s and I would like a referral for a breast cancer risk assessment given my community's elevated risk. Those words give your GP the clinical context they need.

After any mammogram, ask: what is my breast density classification? If you are told you have heterogeneously dense or extremely dense breasts, ask what supplemental imaging options are available. Dense Breasts UK at densebreasts.co.uk is a UK patient advocacy organisation working specifically on density notification.

If you have been through treatment for breast cancer — specifically triple-negative — a finding from the San Antonio Breast Cancer Symposium in December 2025 deserves to reach you. Black women with triple-negative breast cancer are significantly less likely to receive the most advanced available therapies — immunotherapy, antibody-drug conjugates, PARP inhibitors — than White women with the same diagnosis. If you are in treatment or follow-up, ask specifically: what are the most advanced options for my specific subtype, and am I receiving them? You are entitled to that answer.

Black Women Rising — founded by Leanne Pero after her own triple-negative breast cancer diagnosis — provides a weekly clinical nurse specialist support line, monthly in-person groups in London, and online support groups accessible across the UK. Not a crisis line. A community. One worth being part of before you need it rather than when you do. Their website is blackwomenrisinguk.org.

The silence in South Asian communities — named directly, without judgment

In some South Asian households, cancer is not a word that is said. Not because people don't know what it is. Because naming it carries a weight — of stigma, of fear about what it signals for a family, for a woman's standing, for what the community will think — that makes it easier not to name it at all. The silence is protective. It is a response to real social stakes. And it costs people the conversations, the information, and the support they need.

Some South Asian women have gone through cancer treatment without telling their own families. Some have kept the chemotherapy secret. Not because they wanted to carry it alone, but because the alternative — the pity, the shift in how the community sees them, the questions about what this means for their family — felt worse.

But here is the thing that goes even deeper and is almost never named. Many South Asian women who go through cancer become, in their families and communities, the strong one. They manage their own fear while managing everyone else's. They translate clinical information for relatives who are frightened. They hold the household together during treatment. They perform recovery before they have recovered because the people around them need them to. They absorb other people's distress about their cancer while carrying their own distress privately. And when treatment ends, there is often no one to ask: how are you actually? Because everyone around them needed them to be fine, and they were so effective at being fine that the question stopped being asked.

If this is your experience — if you have been the one holding everything together — this chapter sees that. The weight of it is real. And there are spaces where it can be set down.

Sakoon Through Cancer — the word sakoon means peace and tranquillity in Urdu — was founded in 2018 by Samina Hussain, who went through breast cancer herself and found that no existing service understood her specific experience as a South Asian woman. It provides confidential support through peer befriending, groups, and a community of women who have been through it. Importantly, it does not tell your family. Your confidentiality is protected. Contact at sakoonthroughcancer.org, phone 07904 864448.

The Asian Women Cancer Group, based in Harrow, was set up by Asian women who have had cancer themselves. It provides support, groups, and events grounded in genuine cultural understanding rather than well-meaning approximation. Contact at asianwomencancergroup.co.uk.

Faith, community, and what the system gets wrong about both

For many people from South Asian, African, and Caribbean communities, faith is the primary framework through which illness is understood and through which recovery is navigated. This is not a deficit. It is a resource. Faith communities often provide the sustained, practical, emotionally present support that cancer services cannot match — meals cooked, children collected, hospital visits organised, prayer offered, a presence that continues long after the formal support structures have stood down.

But faith frameworks can also make certain aspects of post-treatment life harder to access. And this needs to be said directly, because most cancer resources either ignore it or glide past it.

If illness is understood as God's will or as a test of faith, then struggling after treatment — being frightened, being depressed, not recovering at the pace your community expects — can feel like a failure of faith rather than a normal human response to a serious illness. Seeking psychological support can feel like admitting that prayer and community are not enough. Naming depression or anxiety can feel incompatible with what your community expects of you. And if your community's framework is that you have been tested and you have come through, and now is a time for gratitude and strength, then the ongoing struggle of the post-treatment period has nowhere to go.

A 2022 study of Muslim women in Scotland, examining faith-based interventions in cancer screening, found that cultural barriers — the specific social expectations of a community — were often more significant than religious doctrine itself. Most mainstream faith traditions have more space for human suffering and psychological difficulty than community norms sometimes allow. The gap between what faith actually teaches and what the community expects can itself be a source of additional pressure.

What this means practically: if the honest version of where you are — frightened, not yet recovered, carrying more than you can show — has no safe place in your immediate community, that is the situation Sakoon Through Cancer, the Macmillan community, and the services named throughout this chapter exist for. They are confidential. They are available at hours when everything else is closed. They do not require you to perform anything.

Macmillan's Support Line on 0808 808 00 00 has access to interpretation services. Tell them at the beginning of the call what language you need. This is available now, tonight, in the language you think most clearly in.

Cervical screening — specifically for South Asian women

South Asian women have the lowest cervical screening uptake of any ethnic group in the UK. The barriers are documented and specific: embarrassment about the intimate nature of the examination, concern about who will perform it, the question of whether a female clinician can be requested, the intersection of faith and modesty, language, and — again — the absence of women in the community who had told them what to expect.

None of these barriers are irrational. All of them are addressable.

You can request a female clinician for any intimate examination including cervical screening. This is your right. You do not need to give a reason. Call the surgery before the appointment and say: I would like a female nurse or doctor for my cervical screening. That is all.

Cervical screening is not a cancer test. It looks for cell changes before cancer develops. Most results are normal. Jo's Cervical Cancer Trust at jostrust.org.uk has information in multiple languages about what the procedure involves and what the results mean.

Blood cancers — what Black and South Asian communities need to know

Multiple myeloma is two to three times more common in Black people than in White people. People of African-Caribbean origin are significantly more likely to develop it, and more likely to be younger at diagnosis. This is confirmed by Myeloma UK, Blood Cancer UK, and Cancer Research UK.

If you are from an African-Caribbean background and you have unexplained bone pain, persistent tiredness, frequent infections, or recurring anaemia — these are worth raising with your GP specifically in the context of your community's elevated risk. Myeloma is often diagnosed late because its early symptoms are easily attributed to other things. Knowing to ask changes the conversation.

There is a second dimension. A study examining eighteen years of UK clinical trial enrolment for myeloma found that Black patients — who make up 5.4 per cent of myeloma cases in England — represented just 2.2 per cent of clinical trial participants over that period. The treatments your clinical team may be offering, the decisions being made about your care, rest substantially on evidence from which your community was largely absent.

In November 2024, the National Institute for Health and Care Research made ethnic diversity a formal condition of research funding. This matters for the future.

If your team asks whether you would consider a clinical trial, the question deserves serious thought. Your participation builds the evidence base that will improve treatment for people from your community for years to come. Blood Cancer UK's helpline is 0808 2080 888. Their website at bloodcancer.org.uk has specific information on blood cancer in Black and South Asian communities.

If you are LGBTQ+ and from an ethnic minority community

This is the intersection most cancer resources don't attempt, and the one where the failure to name it causes the most specific and sustained harm.

If you are a Black, South Asian, or ethnic minority person and you are also LGBTQ+, you are navigating a healthcare system that wasn't built for either of your identities. The cancer experiences described in this chapter — the dismissal in clinical settings, the cultural silence, the pressure to perform strength, the absence of people who look like you in the campaigns — exist alongside the additional layers of navigating a system that frequently assumes heterosexual, cisgender bodies and relationships. Clinical forms that don't reflect your household. Assumptions about your body. Encounters where your identity is an afterthought.

And outside the clinical system, you may also be navigating communities — whether family, faith, or cultural — where being LGBTQ+ is not openly acknowledged, which means the support networks that exist for other people in your community may not be fully available to you.

OUTpatients is the UK's only LGBTIQ+ cancer charity. It is led by and for LGBTIQ+ people affected by cancer and provides peer support groups, advocacy, and resources specifically for this experience — including for people of colour navigating both sets of identities at once. Their website is outpatients.org.uk. The Macmillan online community has a dedicated LGBTIQ+ forum at community.macmillan.org.uk where you don't have to explain either context before the conversation can begin.

You are entitled to the same quality of care as anyone else. All of it — as a cancer patient, as a person from an ethnic minority community, and as a person who is LGBTQ+. None of those identities makes you less deserving of excellent care. All of them are served better by services that see the whole person rather than parts of it.

Language and interpretation — the right you may not know you have

If English is not your first language, you have the right to a professional interpreter at any NHS appointment. Not as a favour. As a legal obligation on the NHS under its statutory duties.

Contact the surgery or hospital appointments team before any appointment and say: I would like a professional interpreter in [language] for this appointment. You should not need to justify this.

There is something worth saying about family members as interpreters in cancer settings. A family member translating for you in a consultation about your diagnosis or treatment is simultaneously managing their own fear while trying to convey clinical information accurately. They may soften bad news. They may not translate your questions fully because they are frightened of the answers. They may know things about your health before you do. Professional interpretation protects both of you and ensures you receive complete, accurate information.

Macmillan's Support Line on 0808 808 00 00 has access to interpretation services. Tell them at the beginning of the call what language you need.

Medical mistrust — why it's rational and what it costs

The lower screening uptake, the later presentation, the reluctance to fully trust a system that says it's there to help — in Black communities particularly, none of this can be understood without its context.

The context is the accumulated present-day experience of dismissal in clinical settings. The consistent evidence that Black patients are treated differently. The sense — based on experience, confirmed by fifteen years of annual survey data — that the system was not built for you and does not work equally for you. Historical events — the Tuskegee syphilis study, the story of Henrietta Lacks whose cells were taken and commercialised without her or her family's knowledge, the pulse oximeters whose inaccuracy on darker skin was known but not acted on — these sit in the background, but in the UK the more immediate driver is the ongoing present. What happened at the last appointment. What was said, or not said. Whether the symptom was taken seriously.

The NHS Race and Health Observatory's survey on trust in NHS primary care found high levels of mistrust among Black, Asian, and ethnic minority patients. That mistrust is rational. It is a response to documented reality, not a perception to be corrected by better communications.

And it has a cost. Because the system that produces the experiences that generate the mistrust is also the system that provides early diagnosis, screening, follow-up, and treatment. Avoiding it, or coming to it later than is safe, for reasons that make complete sense, produces worse outcomes for the people it has already failed.

There is no clean resolution. What there is: a growing number of organisations led by people from within the communities they serve. Cancer Black Care, Black Women Rising, Sakoon Through Cancer, the Asian Women Cancer Group, OUTpatients — these are all doing the work the system hasn't done. The change that will actually improve cancer outcomes in these communities will not come primarily from NHS communications departments. It will come from within communities, from people who have been through it talking to people who haven't, in languages, spaces, and registers that those communities trust.

A brief word for communities this chapter couldn't fully cover

Chinese communities in the UK have among the lowest cancer screening uptake rates of any ethnic group. Cancer is frequently not named within families. The barriers to screening include language, cultural fatalism around cancer — the belief that a diagnosis is a death sentence and that screening only confirms a feared outcome — and the absence of Chinese-community-specific information. The Chinese National Healthy Living Centre at cnhlc.org.uk provides health information and support in Mandarin and Cantonese. Macmillan's Support Line has interpretation in Mandarin and Cantonese.

Eastern European communities who have migrated to the UK face their own specific challenges — navigating an unfamiliar healthcare system, the possibility of a different cultural relationship to cancer disclosure, and healthcare workers who may not understand their specific context. The 2025 Cancer Medicine study of African and Eastern European communities in Scotland found that community connectors — people from within communities who could bridge trust — were the most effective route into engagement with cancer services. If you are in an Eastern European community and navigating cancer care, Citizens Advice can help with NHS access and rights.

What to do this week

If you have a symptom that concerns you and you have been holding back from seeking help — partly because of previous experiences in the system that have not given you reason to trust it easily — please do not let that delay become dangerous. You can change your GP. You can bring someone with you. You can call Macmillan before your appointment and have them arrange interpretation, help you frame what you need to say. None of these routes are perfect. All of them are better than a worrying symptom going unexamined. Your life is worth the call — even when the system has not always behaved as if it is.

• Prostate Cancer UK (Risk Checker, helpline, Buddy Scheme) — prostatecanceruk.org
• Prostate Cancer UK Risk Information Service: 0800 448 0821
• Prostate Cancer UK helpline: 0800 074 8383
• Cancer Black Care (Black community and people of colour): cancerblackcare.org.uk or 07340 471 970 — cancerblackcare.org.uk
• Black Women Rising (women of colour, weekly CNS support line, monthly London meetups, online groups) — blackwomenrisinguk.org
• Dense Breasts UK (patient advocacy on breast density notification) — densebreasts.co.uk
• Asian Women Cancer Group (South Asian women) — asianwomencancergroup.co.uk
• Sakoon Through Cancer (South Asian women, confidential): sakoonthroughcancer.org or 07904 864448 — sakoonthroughcancer.org
• OUTpatients (UK's only LGBTIQ+ cancer charity, peer support, advocacy) — outpatients.org.uk
• Blood Cancer UK (helpline, information on blood cancer in Black and South Asian communities): bloodcancer.org.uk or 0808 2080 888 — bloodcancer.org.uk
• Breast Cancer Now (breast cancer information for ethnic communities) — breastcancernow.org
• Jo's Cervical Cancer Trust (multilingual cervical cancer resources) — jostrust.org.uk
• Chinese National Healthy Living Centre (Mandarin and Cantonese health information) — cnhlc.org.uk
• Macmillan Support Line (free, interpretation available in multiple languages, 8am–8pm seven days): 0808 808 00 00
• Macmillan LGBTQ+ cancer information and forum — macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/lgbtq-cancer
• NHS Race and Health Observatory — nhsrho.org
• Bowel screening replacement kit (England): 0800 707 60 60
• PALS (Patient Advice and Liaison Service, for concerns about your care): find via your hospital's website or nhs.uk — nhs.uk
• Equality Advisory and Support Service (discrimination concerns): equalityadvisoryservice.com or 0808 800 0082 — equalityadvisoryservice.com